GBA1 and Parkinson disease: Both homozygous and heterozygous GBA1 mutation carriers have a similar risk for the development of PD, but no accumulation of GCase substrate has yet been observed in PD brains with GBA1 mutations (Gegg et al., 2015; Neumann et al., 2009).